Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30691701 | 0.78 | — | — | |
| SCHEMBL30691799 | 0.77 | — | — | |
| SCHEMBL30691149 | 0.76 | DPP4 (0.33) | DPP4 | |
| SCHEMBL30691036 | 0.76 | — | — | |
| SCHEMBL30691524 | 0.76 | DPP4 (0.33) | DPP4 | |
| SCHEMBL30691382 | 0.75 | MEN1 (0.32) | — | |
| SCHEMBL30691530 | 0.75 | MEN1 (0.32) | — | |
| Formic Acid SCHEMBL30691201 | 0.74 | — | — | |
| SCHEMBL30691280 | 0.73 | MCHR1 (0.33) | — | |
| SCHEMBL30691707 | 0.73 | KDM1A (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119997954-A | Compounds for the treatment of spinocerebellar ataxia type 3 | PTC医疗公司 | 2025-05-13 | — | — | CN | disclosed |
| EP-4543444-A1 | COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 | PTC Therapeutics, Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023250316-A1 | COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 | PTC THERAPEUTICS, INC. (US) | 2023-12-28 | — | — | WO | disclosed |